LARGE-SCALE CLINICAL AND POPULATION-BASED RESEARCH
Professor Christopher Reid,
Cardiovascular Epidemiologist & Research Professor, School of Public Health & Preventive Medicine, Monash University, Victoria, Australia & School of Population Health at Curtin University, Western Australia & Chair, Australian Clinical Trials Alliance (ACTA)
RESEARCHER PROFILE
Filmed in Perth, Australia | October 2026
Christopher Reid is an internationally renowned cardiovascular epidemiologist with appointments as a Research Professor in both the School of Population Health at Curtin University and the School of Public Health and Preventive Medicine, at Monash University.
He was re-appointed as a John Curtin Distinguished Professor in 2021 and is currently Director of the Monash and Curtin Centre for Clinical Research and Education (CCRE). He has been awarded over $178M as a Chief Investigator and has received continuous NHMRC funding since 2001.
His major research interests include clinical outcome registries, randomised controlled trials, and epidemiological cohort studies. He has over 820 peer-reviewed publications (with over 44000 citations and a H-Index of 91) many of which are in leading journals including the New England Journal of Medicine, the Lancet, JAMA, JACC, and the BMJ.
He is a Chief Investigator for the Colchicine in Type 2 diabetes trial (COLCOT-T2D), the Aspirin in the Elderly (ASPREE) trial, the HOPE-3 trial, the Statins in Reducing Events in the Elderly (STAREE) trial and the LEADER-PAD trial. He is also the research director for the Australian and New Zealand Cardiothoracic database (ANZSCTS) registry and the Victorian Cardiac Outcomes registry (VCOR).
He is the Board Chair of the Australian Clinical Trials Alliance (ACTA) and a board member of the Australian New Zealand Alliance for Cardiovascular Trials (ANZACT) Network and the Australian Cardiovascular Alliance (ACVA).
Prof Reid has trained more than 30 PhD students to completion and undertaken assignments for the World Health Organization in cardiovascular disease prevention in the Asia Pacific Region.
Source: Supplied
https://orcid.org/0000-0001-9173-3944
-
Identification, characterisation and role of leader cells in ovarian cancer progression
Dr. Maree Bilandzic is a molecular cancer biologist dedicated to advancing the understanding and treatment of ovarian cancer (OC). Her research addresses critical gaps in OC treatment by investigating the mechanisms behind metastasis, chemotherapy resistance, and tumour recurrence. By utilising innovative methodologies and disease-representative models, Dr. Bilandzic has pioneered the identification and characterisation of leader cells (LCs)—a unique, stem-like subpopulation within tumours that plays a crucial role in OC progression.
-
Access to dental care for priority populations
Professor Dileep Sharma is a distinguished dental educator and researcher who currently serves as Professor and Discipline Head of Oral Health at the University of Newcastle, Australia. With over two decades of experience spanning clinical practice, research leadership, and academic mentorship, Professor Sharma has established himself as a leading authority in oral health education and interdisciplinary research.
-
Precision and personalised nutrition
Laureate Professor Clare Collins is helping people access effective medical nutrition therapies that significantly reduce their risk of chronic disease. She and her team are developing innovative technologies, including apps and online programmes.
